Published • loading... • Updated
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO
The biotech plans to sell 9.38 million shares and could be valued at up to $805.8 million at the top of the range.
4 Articles
4 Articles
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO - Regional Media News
Oct 8 (Reuters) - Iambic Therapeutics, which is backed by Nvidia, is aiming to raise as much as $159.4 million in its US IPO, a regulatory filing showed on Thursday, as biotech companies remain a bright spot in an otherwise subdued IPO market. At the [...]
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO
Oct 8 (Reuters) - Iambic Therapeutics, which is backed by Nvidia, is aiming to raise as much as $159.4 million in its US IPO, a regulatory filing showed on Thursday, as biotech companies remain a bright spot in an otherwise subdued IPO market. At the...
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
